KHC
17
4
AMG
43
3
AAPL
45
3
BK
72
-2
JCI
61
-2
EMN
50
-2
DOV
73
4
AA
38
-2
CSX
68
3
STI
31
19
QCOM
55
-2
TXT
62
2
EFX
41
-2
NSC
64
2
ZTS
49
2
PDCO
30
-6
MRO
46
3
DIS
62
2
R
77
2
T
48
3
KHC
17
4
AMG
43
3
AAPL
45
3
BK
72
-2
JCI
61
-2
EMN
50
-2
DOV
73
4
AA
38
-2
CSX
68
3
STI
31
19
QCOM
55
-2
TXT
62
2
EFX
41
-2
NSC
64
2
ZTS
49
2
PDCO
30
-6
MRO
46
3
DIS
62
2
R
77
2
T
48
3
Financhill
Back

OncoCyte Vs. ePlus Industry Stock Comparison

Sell
50

OCX
OncoCyte

Last Price:
2.80
Seasonality Move:
46.75%
Sell
27

PLUS
ePlus

Last Price:
80.50
Seasonality Move:
20.86%
Sell
50
OncoCyte (OCX) is a Sell

Is OncoCyte a Buy, Sell or Hold?

  • The current OncoCyte [OCX] share price is $2.90. The Score for OCX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • OCX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
ePlus (PLUS) is a Sell

Is ePlus a Buy, Sell or Hold?

  • The current ePlus [PLUS] share price is $80.03. The Score for PLUS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • PLUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

OCX Stock Price Chart

What is OncoCyte's stock price today?

  • The OncoCyte share price today is $2.90
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCX is experiencing slight selling pressure.

PLUS Stock Price Chart

What is ePlus's stock price today?

  • The ePlus share price today is $80.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLUS is experiencing selling pressure, which indicates risk of future bearish movement.

OCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 43.58 Sell
Chaikin Money Flow: -1634 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.92 - 3.12) Sell
Bollinger Bands (100): (2.92 - 3.2) Sell

PLUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.37 Sell
Relative Strength Index (14 RSI): 28.12 Sell
Chaikin Money Flow: -371573 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (91.15 - 100.85) Sell
Bollinger Bands (100): (81.19 - 98.29) Sell

OCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.89 Buy
20-day SMA: 3 Sell
50-day SMA: 3.03 Sell
200-day SMA: 2.95 Sell
8-day EMA: 2.91 Sell
20-day EMA: 2.96 Sell
50-day EMA: 3.01 Sell
200-day EMA: 3.24 Sell

PLUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 93.25 Sell
20-day SMA: 94.97 Sell
50-day SMA: 95.27 Sell
200-day SMA: 83.59 Sell
8-day EMA: 92.26 Sell
20-day EMA: 94.28 Sell
50-day EMA: 94.05 Sell
200-day EMA: 84.44 Sell

OncoCyte Earnings Growth & OCX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.

ePlus Earnings Growth & PLUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.53 per share, and a decrease next year of $0.07 per share.

OncoCyte Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ePlus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):